Publication:
Clinicopathological outcomes of microsatellite instability in colorectal cancer

dc.contributor.authorERGENÇ, MUHAMMER
dc.contributor.authorsGülşen T., Ergenç M., Şenol Z., Emirzeoğlu L., Güleç B.
dc.date.accessioned2023-05-22T07:36:08Z
dc.date.accessioned2026-01-11T15:31:53Z
dc.date.available2023-05-22T07:36:08Z
dc.date.issued2022-11-01
dc.description.abstractAims:This study aims to evaluate the histopathological features and prognostic parameters of tumors withmicrosatellite instability(MSI) compared with those without MSI in patients who underwent surgery forcolorectal cancer(CRC).Setting and Design:Follow-up for CRC at Istanbul Sultan 2. Abdulhamid Han Training and Research Hospital was retrospectively evaluated between March 2017 and March 2021.Methods and Material:The patients were divided into two groups: those with and without MSI. Groups were compared insurvivalparameters. As a secondary result, groups were compared in pathological parameters such as stage, tumor diameter, degree of differentiation, and lymphovascular, and perineural invasion.Statistical Analysis Used:Survivalcalculations were performed using the Kaplan–Meier analysis method. The effects of various prognostic factors related to tumor and patient characteristics on disease-free and overallsurvival(OS) were investigated by log-rank test.Results:Two hundred fourteen patients were analyzed. The median age of the patients was 66 (30–89), and 59.3% (n = 127) were male. There were 25 patients in the MSI group and 189 patients in the non-MSI group. We found that MSI tumors had a significantly higher differentiation degree than non-MSI tumors and larger tumor diameters. MSI tumors frequently settled in the proximal colon, and more lymph nodes were removed in the resection material. MSI tumors had longer disease-freesurvival, cancer-specificsurvival, and overallsurvival.Conclusions:By diagnosingmicrosatellite instability, CRCs can be divided into two groups. The histopathological features of the tumor and theprognosisof the disease differ between these groups. MSI can be a predictive marker in the patient’s follow-up and treatment.
dc.identifier.citationGülşen T., Ergenç M., Şenol Z., Emirzeoğlu L., Güleç B., "Clinicopathological outcomes of microsatellite instability in colorectal cancer", JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, cilt.0, sa.0, 2022
dc.identifier.issn1998-4138
dc.identifier.issue0
dc.identifier.urihttps://journals.lww.com/cancerjournal/Abstract/9000/Clinicopathological_outcomes_of_microsatellite.99901.aspx
dc.identifier.urihttps://hdl.handle.net/11424/289468
dc.identifier.volume0
dc.language.isoeng
dc.relation.ispartofJOURNAL OF CANCER RESEARCH AND THERAPEUTICS
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectSağlık Bilimleri
dc.subjectHealth Sciences
dc.subjectKlinik Tıp (MED)
dc.subjectClinical Medicine (MED)
dc.titleClinicopathological outcomes of microsatellite instability in colorectal cancer
dc.typearticle
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
1.49 MB
Format:
Adobe Portable Document Format